EHA would like to thank the following partners for their support in 2023:

Recognition of sponsors, partners and collaborators

PLATINUM SPONSORS

GOLD SPONSORS

SILVER SPONSORS

BRONZE SPONSORS

CONTRIBUTORS

Patient organizations collaborating with EHA

EHA greatly values the collaboration with patient organizations in a growing number of areas, from joint advocacy and a strong presence at the EHA Annual Congress to advice on scientific and educational activities. View all 14 patient organizations that make up the EHA Patient Advocacy Committee (EHA PAC) here.

In 2023 EHA collaborated with the following Scientific Networks:

EHA SWG

EHA supports the 24 EHA-SWGs by allocating session slots in its Annual Congress program, organizing dedicated scientific meetings, and facilitating guideline production, amongst other activities. In 2023, two SWG scientific meetings were held in Budapest, Hungary, focusing on novel research, diagnostic, and treatment developments.

CarrerasLeaders

CarrerasLeaders is a postdoc fellowship and training program for the next generation of researchers. Coordinated by the Josep Carreras Leukaemia Research Institute, EHA supported promotion efforts in 2023 for the new call for 16 CarrerasLeaders post-doctorate research projects.

EBN

Launched in early 2017, EuroBloodNet (European Reference Network for rare hematological diseases) was born from the joint efforts of EHA and the European Network for Rare Congenital Anemias (ENERCA) to bring together over 100 highly specialized hospital centers with expertise on malignant and non-malignant rare hematological diseases. In 2023, we worked together to support various ERN webinar series, raising awareness of rare hematologic diseases.

COST

In 2023, EHA and EuNet INNOCHRON, a COST Action, offered attendance grants for young researchers to attend the EHA2023 Annual Congress. We also published a collaborative guideline on the definition, classification, diagnosis, and follow-up for the full spectrum of patients with chronic neutropenias.

The European Cooperation in Science and Technology (COST) is an EU-funded, intergovernmental framework that aims to create pan-European research networks in all science fields and promote excellence, foster interdisciplinary research and empower young researchers and innovators.

INTERCEPT-MDS MSCA

EHA is a proud associated partner of the INTERCEPT-MDS MSCA Doctoral Network. In 2023, EHA supported the promotion of a new call for doctorate positions.

HTA Stakeholder Network

EHA is a partner of the HTA Stakeholder Network. In 2023, EHA contributed expert speakers to support discussions about the potential impacts of HTA at the EAA Fall Convention.

T2EVOLVE

T2EVOLVE is a breakthrough alliance working to accelerate development and increase access to immunotherapy with immune cells that harbor a genetically engineered T-cell receptor (TCR) or synthetic chimeric antigen receptor (CAR).

In 2023, the website underwent significant expansion under EHA’s leadership. It now features a patient hub with relevant resources for patients undergoing CAR T-cell therapy, as well as a hub for healthcare professionals providing learning materials.

The alliance is financially supported by IHI and successfully completed its mid-term review. EHA supported sessions hosted at the European CAR T-cell Meeting, the EBMT Annual Meeting, EHA2023, and the ASH Congress.

HARMONY

The HARMONY Alliance, public-private partnership for big data in hematology, aims at unlocking and spreading valuable knowledge on hematologic cancers with the goal to harness and mine big data to speed up the development of improved treatments for patients and more effective treatment strategies.

As a long-term partner, EHA, in 2023, guided HARMONY to communicate the value of data-driven research and establish meaningful European and international connections. EHA SWGs contributed scientific expertise through various big data research projects. At the EHA2023 Annual Congress, apart from scientific abstract presentation and networking opportunities at the exhibition, HARMONY hosted a dedicated session about the impact of real-world data and real-world evidence on research and clinical care.

SUPPLY

Strengthening voluntary non-remunerated plasma collection capacity in Europe (SUPPLY) is an EU4Health-funded project that started on September 1, 2022 and ended in February 2023. In 2023, EHA worked with project partners to ensure the views of hematology were heard during the European Commission's discussion of the Substances of Human Origin (SoHo) regulation.

TOLERATE

TOLERATE is an interdisciplinary and intersectoral training network focused on developing innovative antigen-specific immune therapies for autoimmune diseases. It builds on the experiences of the PROFILE Innovative Training Network (ITN).

EHA is supporting TOLERATE as associate partner, offering the project the opportunity to raise awareness of its aims at the EHA2023 Annual Congress.

GoCART

GoCART Coalition is a multi-stakeholder coalition collaborating to maximize the potential of cellular therapies manufactured from cells and tissues of hematopoietic origin. The coalition was co-founded by EHA and EBMT, and EHA leads on website and media.

In 2023, the coalition's pharmacist and apheresis working groups published CAR T guidance documents, and it started new projects on the development of a CAR T-passport for healthcare professionals and a Cord Data set for CAR T.

National societies

EHA pursues ongoing close collaboration with 43 national hematology societies to ensure that the professional hematology community in Europe is served in the best possible way. In 2023, we expanded our joint membership programs to include Turkey, Romania, Albania, Armenia, and Bulgaria – offering more benefits and access to resources to hematologists in Europe than ever before.